BioRegen Biomedical (Changzhou) Co.,Ltd.

The poor healing  of the mucosal wound with loss of function after ENT surgery is a serious problem, which has been paid more and more attention by ENT experts and may interfere the final efficacy of the treatment. Solutions are truly needed to address this sticky problem. BioRegen has designed a new kind of biomaterial (PureRegen Gel Sinus) of hyaluronic acid gel to address the problems. We use the sodium hyaluronate from biological fermentation as raw material, manufacture with unique and proprietary cross-linking technology, accurately regulate absorption time and viscosity to ensure sufficient intervention treatment so as to improve the safety and effectiveness in wound healing.

1) Relieving postoperative debridement workload. 

2) Consolidating and improving surgical effect. 

3) Enabling moisturizing lubrication and effective prvention of wound oxidization to improve patient confort and reduce pain. 

4) Controlling small amount of errhysis, supporting wound tissue, effectively isolating woound and avoiding mucosal secondary injury. 

5) Regulating inflammation, and reducing edema . 

6) Reducing postoperative vesicles formation and incrustation.

7) Accelerating mucosal epithelization.

8) Promoting the regeneration of cilia.

9) Preventing adhesion and scarring.

Instruction For Use

-Applicable sites:

Mucosal wound

Mucosal surface possibly injured/infected during surgery

-Application steps:

1) Open the protection carton box and pull the product pack out.

2) Following the indication peel-open the package, remove the PureRegen Gel Sinus from the package and place on the sterile field.

3) Remove the tip cap from the syringe.

4) Attach the moldable delivery cannula with the syringe. The cannula is packed inside the same box as for the gel.

5) Upon completion of the FESS, inject the PureRegen Gel Sinus to fill the cavity and cover all mucosa until small amount of gel leaking out from the ostiomeatal.